Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus

Horm Metab Res. 2023 Jul;55(7):487-492. doi: 10.1055/a-2093-0260. Epub 2023 May 13.

Abstract

The aims of this study were in systemic lupus erythematosus (SLE) patients: 1) to compare the metabolomic profile of insulin resistance (IR) with controls and 2) to correlate the metabolomic profile with other IR surrogates and SLE disease variables and vitamin levels. In this cross-sectional study, serum samples were collected from women with SLE (n=64) and gender- and age-matched controls (n=71), which were not diabetic. Serum metabolomic profiling was performed using UPLC-MS-MS (Quantse score). HOMA and QUICKI were carried out. Serum 25(OH)D concentrations were measured by chemiluminescent immunoassay. In women with SLE, the metabolomic Quantose score significantly correlated with HOMA-IR, HOMA2-IR, and QUICKI. Although concentrations of IR metabolites were not different between SLE patients and controls, fasting plasma insulin levels were higher and insulin sensitivity lower in SLE women. Interestingly, the Quantose IR score was significantly correlated with complement C3 levels (r=0.7; p=0.001). 25 (OH)D did not correlate with any metabolite or the Quantose IR index. Quantose IR may be a useful tool for IR assessment. There was a possible correlation between the metabolomic profile and complement C3 levels. The implementation of this metabolic strategy may help develop biochemical insight into metabolic disorders in SLE.

MeSH terms

  • Chromatography, Liquid
  • Complement C3
  • Cross-Sectional Studies
  • Female
  • Humans
  • Insulin
  • Insulin Resistance*
  • Lupus Erythematosus, Systemic*
  • Tandem Mass Spectrometry

Substances

  • Complement C3
  • Insulin